GlassScriptPhysician profile
Jovil Kannampuzha
NPI 1710329776
$2,143.85
in general payments reported to CMS, 2019-2025
16 companies · $730 in 2025
The $730 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $236 · 2020: $55.35 · 2021: $135 · 2023: $686 · 2024: $301 · 2025: $730.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,500 · Travel and Lodging: $216.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,500.42 |
| Travel and Lodging | $216.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,004.63 | 2019-2025 | Watchman Access System, Watchman Flx |
| Abiomed | $178.04 | 2023-2025 | Impella |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $177.26 | 2020-2024 | Lifevest |
| Astrazeneca Pharmaceuticals LP | $147.64 | 2025 | Wainua |
| United Therapeutics Corporation | $137.75 | 2024 | Tyvaso, Orenitram, Remodulin |
| Inspire Medical Systems, INC. | $121.88 | 2025 | Inspire |
| Pfizer INC. | $81.13 | 2021-2025 | |
| Kestra Medical Technology Services, INC. | $68.05 | 2025 | Assure Wcd |
| Janssen Pharmaceuticals, INC | $51.14 | 2021 | |
| Novo Nordisk INC | $39.23 | 2023 | Ozempic |
| Lantheus Medical Imaging, INC. | $31.53 | 2020-2021 | |
| W. L. Gore & Associates, INC. | $25.53 | 2023 | Viatorr Tips Endoprosthesis W/ Controlled Expansion |
| Abbott Laboratories | $25.12 | 2023 | Perclose Prostyle |
| Imperative Care, INC | $25.09 | 2025 | Symphony Catheter |
| Edwards Lifesciences Corporation | $17.80 | 2023 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $12.03 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jovil Kannampuzha listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.